Toggle Health Problems and D

Rate of falls reduced 2X by just 1000 IU of vitamin D – RCT Nov 2015

Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial.

Menopause. 2015 Nov 2. [Epub ahead of print]
Cangussu LM1, Nahas-Neto J, Orsatti CL, Poloni PF, Schmitt EB, Almeida-Filho B, Nahas EA.
1 Department of Gynecology and Obstetrics, Botucatu Medical School, Sao Paulo State University-UNESP, Sao Paulo, Brazil.

VitaminDWiki Summary

9 months of 1,000 IU vitamin D daily
Women aged 50-65 who had fallen during previous year

Before AfterFall Rate Recurrent fall rate
Placebo17 ng 14 ng - -
Get 1,000 IU15 ng 27 ng 2 X reduction 2.8 X reduction

Far fewer falls could be expected with larger dose of vitamin D – so as to get > 35 ng

See also VitaminDWiki

The Meta-analyses of Falls/Fractures

To evaluate the effect of isolated vitamin D supplementation (VITD) on the rate of falls and postural balance in postmenopausal women fallers.

In this double-blind, placebo-controlled trial, 160 Brazilian younger postmenopausal women were randomized into two groups: VITD group, vitamin D3 supplementation 1,000 IU/day/orally (n = 80) and placebo group (n = 80). Women with amenorrhea at least 12 months, age 50 to 65 years, and a history of falls (previous 12 months) were included. Those with neurological or musculoskeletal disorders, vestibulopathies, drugs use that could affect balance and osteoporosis were excluded. The intervention time was 9 months. Postural balance was assessed by stabilometry (computerized force platform) and investigation on the occurrence/recurrence of falls was performed by interviews. The plasma concentration of 25-hydroxyvitamin D [25(OH)D] was measured by high-performance liquid chromatography. Statistical analysis was achieved by intention-to-treat, using analysis of variance, Student's t test, Tukey test, chi-square, and logistic regression.

After 9 months, mean values of 25(OH)D increased from 15.0 ± 7.5 ng/mL to 27.5 ± 10.4 ng/mL (+45.4%) in the VITD group, and decreased from 16.9 ± 6.7 ng/mL to 13.8 ± 6.0 ng/mL (-18.5%) in the placebo group (P < 0.001). The occurrence of falls was higher in the placebo group (+46.3%) with an adjusted risk of 1.95 (95% confidence interval [CI] 1.23-3.08) times more likely to fall and 2.80 (95% CI 1.43-5.50) times higher for recurrent falls compared to the VITD group (P < 0.001). There was reduction in body sway by stabilometry, with lower amplitude of antero-posterior (-35.5%) and latero-lateral (-37.0%) oscillation, only in the VITD group (P < 0.001).

In Brazilian postmenopausal women fallers, isolated vitamin D supplementation for 9 months resulted in a lower incidence of falls and improvement in postural balance.

PMID: 26554884

Vitamin D Council review of study Dec 2015

Includes the following
. . this study satisfied most of Professor Robert Heaney’s suggestions for a high quality vitamin D randomized controlled trial:

  • 1) The women were frequent fallers (they were tested for the condition);
  • 2) baseline 25(OH)D levels were low,
  • 3) a substantial dose of vitamin D was used; (Note:no #4)
  • 5) After nine months, blood tests confirmed the vitamin D group experienced a substantial increase in 25(OH)D levels, while the placebo group did not;
  • 6) a corollary test was performed (balance) that agreed with the primary end point.

The only thing the researchers didn’t do was administer vitamin D co-factors (magnesium, zinc, boron and vitamin K), but very few if any studies do that.

See in VitaminDWiki Why randomized controlled trials of calcium and vitamin D sometimes fail – June 2012